← The Wire
OVIDNasdaq
Ovid Therapeutics Inc.
Pharmaceutical Preparations · DE · CIK 1636651
Ovid Therapeutics develops small molecule medicines for brain disorders by quelling neuronal hyperexcitation
red 8-K · 90d
$429M
Market cap
$2.72
Last close
+6.7%
1D
+20.9%
5D
1.6M
Volume
Price · last 39 sessions-7.2%
May 4L $2.21 · H $2.93Jun 29
230
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 11, 20268-KExecutive ChangeJun 3, 202610-Q10-QMay 12, 20268-KCompany UpdateMay 12, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 20268-KCompany UpdateApr 20, 202610-K10-KMar 18, 20268-KMaterial Agreement · Results of OperationsMar 18, 20268-KCompany UpdateDec 18, 20258-KShareholder VoteDec 11, 202510-Q10-QNov 12, 20258-KExecutive Change · Results of OperationsNov 12, 2025DEF 14ADEF 14ANov 7, 20258-KMaterial Agreement · Equity IssuanceOct 3, 20258-KCompany UpdateSep 16, 202510-Q10-QAug 13, 20258-KCompany UpdateAug 13, 20258-KShareholder VoteJul 10, 20258-KCompany UpdateJun 25, 2025DEFA14ADEFA14AMay 22, 2025DEF 14ADEF 14AMay 22, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 20258-KCompany UpdateMay 2, 202510-K/A10-K/AApr 30, 202510-K10-KMar 11, 20258-KResults of OperationsMar 11, 20258-KExecutive ChangeMar 5, 20258-KDelisting NoticeFeb 13, 202510-Q10-QNov 12, 20248-KCompany UpdateNov 12, 20248-KExecutive ChangeSep 11, 202410-Q10-QAug 13, 20248-KCompany UpdateAug 13, 20248-KExecutive ChangeAug 2, 20248-KCompany UpdateJul 1, 20248-KExecutive Change · Exit / Disposal CostsJun 28, 20248-KReg FD DisclosureJun 17, 20248-KShareholder VoteJun 7, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 2024DEFA14ADEFA14AApr 24, 2024DEF 14ADEF 14AApr 24, 202410-K10-KMar 8, 20248-KResults of OperationsMar 8, 2024SC 13GSC 13GJan 29, 20248-KCompany UpdateDec 6, 2023424B5424B5Nov 15, 202310-Q10-QNov 3, 20238-KResults of OperationsNov 3, 20238-KMaterial Agreement · Reg FD DisclosureOct 18, 20238-KCompany UpdateOct 2, 202310-Q10-QAug 4, 20238-KResults of OperationsAug 4, 2023SC 13GSC 13GJul 31, 20238-KShareholder VoteJun 9, 202310-Q10-QMay 5, 20238-KResults of OperationsMay 5, 20238-KCompany UpdateMay 1, 20238-KCompany UpdateApr 27, 2023DEF 14ADEF 14AApr 27, 2023DEFA14ADEFA14AApr 26, 202310-K10-KMar 13, 20238-KResults of OperationsMar 13, 20238-KReg FD DisclosureMar 10, 2023SC 13GSC 13GFeb 10, 202310-Q10-QNov 8, 20228-KResults of OperationsNov 8, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 20228-KShareholder VoteJun 10, 20228-KCompany UpdateMay 11, 202210-Q10-QMay 10, 20228-KResults of OperationsMay 10, 2022DEFA14ADEFA14AMay 2, 2022DEF 14ADEF 14AApr 29, 202210-K10-KMar 15, 20228-KResults of OperationsMar 15, 2022SC 13GSCHEDULE 13GFeb 10, 2022
Insider Activity
In the 90 days to Feb 23, 2026: 2 sold $29K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Alexander Margaret A.President and CEO | Sell | 11,656 | $1.45 | $17K |
| Feb 23, 2026 | Rona Jeffrey ACBFO | Sell | 8,541 | $1.45 | $12K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance